Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Spiegelberg Jasmin Alija |
** = Publikationen gelistet in SCI/SSCI/Pubmed
2024
Originalarbeit (Zeitschrift)
** Pichler, R; Fritz, J; Maier, S; Hassler, MR; Krauter, J; D, Andrea, D; Laukhtina, E; Gust, K; Mori, K; Tully, KH; Niedersuess-Beke, D; Korber, L; Spiegelberg, JA; Bauernhofer, T; Subiela, JD; Mayr, R; Kronbichler, A; Moschini, M; Teoh, J; Pradere, B; Shariat, SF; Ulmer, H; Mertens, LS, , European, Association, of, Urology–Young, Academic, Urologists, (EAU-YAU):, Urothelial, Carcinoma, Working, Group
Target trial emulation to evaluate the effect of immune-related adverse events on outcomes in metastatic urothelial cancer.
Cancer Immunol Immunother. 2024; 74(1): 30
Doi: 10.1007/s00262-024-03871-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2023
Originalarbeit (Zeitschrift)
** Egger, V; Hutterer, GC; Mischinger, J; Seles, M; Pichler, R; Mannweiler, S; Huber, K; Balihodzic, A; Spiegelberg, J; Bauernhofer, T; Ahyai, S; Zigeuner, R; Pichler, M; Barth, DA
Preoperative fibrinogen/CRP score predicts survival in upper urothelial tract carcinoma patients undergoing radical curative surgery.
World J Urol. 2023; 41(5):1359-1364
Doi: 10.1007/s00345-023-04379-y
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Huemer, M; Pansi, A; Hofmann, G; Terbuch, A; Sciri, E; Lipp, R; Spiegelberg, JA; Jahn-Kuch, D; Pichler, M
Symptom clusters associated with complementary and alternative medicine use by cancer patients: A cross-sectional study.
PLoS One. 2023; 18(12): e0294641
Doi: 10.1371/journal.pone.0294641
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Spiegelberg, J
Renal cell carcinoma
MEMO-MAG EUR MED ONC. 2023;
Doi: 10.1007/s12254-023-00918-w
Web of Science
FullText
FullText_MUG
2022
Originalarbeit (Zeitschrift)
** Barth, DA; Stanzer, S; Spiegelberg, J; Bauernhofer, T; Absenger, G; Posch, F; Lipp, R; Halm, M; Szkandera, J; Balic, M; Gerger, A; Smolle, MA; Hutterer, GC; Klec, C; Jost, PJ; Kargl, J; Stradner, M; Pichler, M
Evaluation of autoantibodies as predictors of treatment response and immune-related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan-cancer study.
Cancer Med. 2022; 11(16):3074-3083
Doi: 10.1002/cam4.4675
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Barth, DA; Stanzer, S; Spiegelberg, JA; Bauernhofer, T; Absenger, G; Szkandera, J; Gerger, A; Smolle, MA; Hutterer, GC; Ahyai, SA; Madl, T; Posch, F; Riedl, JM; Klec, C; Jost, PJ; Kargl, J; Stradner, MH; Pichler, M
Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer Study.
Front Immunol. 2022; 13:840207
Doi: 10.3389/fimmu.2022.840207
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Fluhrer, H; Hutterer, GC; Golbeck, S; Stidl, M; Niedrist, T; Pichler, R; Mischinger, J; Seles, M; Mannweiler, S; Spiegelberg, J; Bauernhofer, T; Jost, PJ; Ahyai, S; Zigeuner, R; Pichler, M; Barth, DA
Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-up.
Ther Adv Med Oncol. 2022; 14: 17588359221134065
Doi: 10.1177/17588359221134065
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2020
Originalarbeit (Zeitschrift)
** Moser, T; Waldispuehl-Geigl, J; Belic, J; Weber, S; Zhou, Q; Hasenleithner, SO; Graf, R; Terzic, JA; Posch, F; Sill, H; Lax, S; Kashofer, K; Hoefler, G; Schoellnast, H; Heitzer, E; Geigl, JB; Bauernhofer, T; Speicher, MR
On-treatment measurements of circulating tumor DNA during FOLFOX therapy in patients with colorectal cancer.
NPJ Precis Oncol. 2020; 4(1):30
Doi: 10.1038/s41698-020-00134-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Moser, T; Waldispuehl-Geigl, J; Belic, J; Perakis, S; Weber, S; Zhou, Q; Sill, H; Lax, S; Kashofer, K; Hoefler, G; Schoellnast, H; Bauernhofer, T; Heitzer, E; Geigl, JB; Speicher, MR
Early circulating tumor DNA dynamics as a real-time predictor of FOLFOX efficacy in advanced colorectal cancer patients
CANCER RES. 2020; 80(16):
Doi: 10.1158/1538-7445.AM2020-4295
[Poster]
Web of Science
FullText
FullText_MUG
2019
Abstract (Zeitschrift)
** Terzic, J; Fillafer, F; Posch, F; Pichler, R; Seles, M; Niedersuss-Beke, D; Tinchon, C; Loidl, W; Pichler, M; Jahn, S; Stoger, H; Bauernhofer, T;
Lymphopenia impairs response to 1st-line tyrosine kinase inhibitor therapy in patients with metastatic clear-cell renal cell carcinoma and modulates the relative efficacy of sunitinib and pazopanib
WIEN KLIN WOCHENSCHR. 2019; 131: S447-S447.-Frühjahrstagung der OeGHO; APR 11-13, 2019; Linz, AUSTRIA.
[Poster]
Web of Science
FullText
** Terzic, J; Tinchon, C; Stoger, H
Smoker's Cough - what's behind it?
WIEN KLIN WOCHENSCHR. 2019; 131: S434-S435.
[Oral Communication]
Web of Science
2018
Abstract (Konferenzband)
** Terzic, J; Fillafer, F; Posch, F; Pichler, R; Seles, M; Pichler, M; Jahn, S; Stöger, H; Bauernhofer, T
Lymphopenia impairs response to 1st-line therapy with
sunitinib and pazopanib in patients with metastatic clear-cell
renal cell carcinoma.
Oncology Research
and Treatment . 2018; 41(Suppl4):42-43.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie,; SEP 28- OCT 2, 2018; Vienna, AUSTRIA. (ISBN: 978-3-318-06425-4 )
[Oral Communication]
Web of Science
FullText
2017
Übersichtsarbeit
** Absenger, G; Terzic, J; Bezan, A
ASCO update: lung cancer.
Memo. 2017; 10(4):224-227
Doi: 10.1007/s12254-017-0373-x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG